Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China · Delayed Price · Currency is CNY 12.66
-0.13 (-1.02%)
Nov 6, 2026, 3:04 PM CST
SHE:002755 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 182.68 | 236.6 | 160.29 | -148.53 | -225.83 | 379.91 |
Depreciation & Amortization | 128.7 | 128.7 | 87.61 | 84.7 | 92.19 | 94.51 |
Other Amortization | 5.29 | 5.29 | 4.57 | 4.85 | 5.67 | 4.15 |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | 0.03 | -0.03 | -0.21 | -0.3 |
Asset Writedown & Restructuring Costs | 0.9 | 0.9 | 3.06 | 5.7 | 1.09 | 0.86 |
Loss (Gain) From Sale of Investments | -5.66 | -5.66 | -27.32 | -26.89 | -29.72 | -20.68 |
Provision & Write-off of Bad Debts | 0.76 | 0.76 | -0.16 | -4.48 | -7.02 | -4.51 |
Other Operating Activities | -324.84 | -20.95 | -26.11 | -52.51 | -13.44 | 4.75 |
Change in Accounts Receivable | 0.97 | 0.97 | -154.15 | 53.45 | 262.97 | 363.45 |
Change in Inventory | 71.01 | 71.01 | -31.38 | -26.41 | -1.79 | 26.89 |
Change in Accounts Payable | 228.03 | 228.03 | 395.15 | 93.18 | -133.44 | -281.03 |
Change in Other Net Operating Assets | 7.14 | 7.14 | -8.32 | -7.34 | -3.61 | 1.92 |
Operating Cash Flow | 293.84 | 651.64 | 411.36 | -26.57 | -52.81 | 567.71 |
Operating Cash Flow Growth | -48.05% | 58.41% | - | - | - | -2.18% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -170.3 | -143.58 | -230.42 | -129.32 | -150.45 | -133.76 |
Sale of Property, Plant & Equipment | 1.46 | 0.17 | 0.66 | 0.59 | 0.88 | 0.94 |
Divestitures | - | 0.52 | - | - | - | - |
Investment in Securities | -147 | -321 | 29.47 | 115 | -315 | -438 |
Other Investing Activities | 17.54 | 23.22 | 27.05 | 25.29 | 25.65 | 7.79 |
Investing Cash Flow | -298.3 | -440.67 | -173.24 | 11.56 | -438.92 | -563.02 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 47 | 101.62 | 154.72 | 45 | - |
Total Debt Issued | 30 | 47 | 101.62 | 154.72 | 45 | - |
Short-Term Debt Repaid | - | -82 | -54 | -65.72 | - | -20 |
Long-Term Debt Repaid | - | -3.95 | -3.34 | -3.08 | -2.91 | -2.76 |
Lease Payments | -3.95 | -3.95 | -3.34 | -3.08 | -2.91 | -2.76 |
Total Debt Repaid | -50.95 | -85.95 | -57.34 | -68.8 | -2.91 | -22.76 |
Net Debt Issued (Repaid) | -20.95 | -38.95 | 44.27 | 85.92 | 42.09 | -22.76 |
Issuance of Common Stock | - | 30 | - | 206.38 | 127.02 | 0.38 |
Repurchase of Common Stock | - | - | - | - | - | -1.6 |
Common Dividends Paid | -111.46 | -111.47 | -1.16 | -1.12 | -93.19 | -185.76 |
Other Financing Activities | 0.18 | - | - | - | - | - |
Financing Cash Flow | -132.23 | -120.43 | 43.11 | 291.17 | 75.91 | -209.74 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -2.32 | -0.76 | 3.09 | -1.2 | 15.6 | -0.02 |
Net Cash Flow | -139.02 | 89.79 | 284.32 | 274.97 | -400.22 | -205.07 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 123.54 | 508.07 | 180.94 | -155.89 | -203.27 | 433.95 |
Free Cash Flow Growth | -52.72% | 180.79% | - | - | - | 13.99% |
Free Cash Flow Margin | 7.76% | 28.56% | 10.18% | -10.80% | -10.85% | 13.97% |
Free Cash Flow Per Share | 0.13 | 0.54 | 0.19 | -0.17 | -0.22 | 0.47 |
Levered Free Cash Flow | 86.54 | 456.23 | 311.79 | -83.12 | -101.11 | 263.79 |
Unlevered Free Cash Flow | 86.74 | 456.79 | 313.44 | -81.37 | -99.38 | 266.28 |
Free Cash Flow After Leases | 119.59 | 504.11 | 177.6 | -158.97 | -206.18 | 431.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Interest Paid | - | - | - | - | - | 0.27 |
Cash Income Tax Paid | 191.04 | 213.04 | 204 | 136.72 | 208.09 | 433.1 |
Change in Working Capital | 305.98 | 305.98 | 209.37 | 110.63 | 124.45 | 109.03 |